Cargando…

Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis

We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled.

Detalles Bibliográficos
Autores principales: Kawaguchi, Yo, Hanaoka, Jun, Hayashi, Hideki, Fukuda, Yoshihisa, Iihara, Hirotoshi, Suzuki, Akio, Sugiyama, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044355/
https://www.ncbi.nlm.nih.gov/pubmed/32128186
http://dx.doi.org/10.1002/ccr3.2645
_version_ 1783501553225695232
author Kawaguchi, Yo
Hanaoka, Jun
Hayashi, Hideki
Fukuda, Yoshihisa
Iihara, Hirotoshi
Suzuki, Akio
Sugiyama, Tadashi
author_facet Kawaguchi, Yo
Hanaoka, Jun
Hayashi, Hideki
Fukuda, Yoshihisa
Iihara, Hirotoshi
Suzuki, Akio
Sugiyama, Tadashi
author_sort Kawaguchi, Yo
collection PubMed
description We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled.
format Online
Article
Text
id pubmed-7044355
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70443552020-03-03 Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis Kawaguchi, Yo Hanaoka, Jun Hayashi, Hideki Fukuda, Yoshihisa Iihara, Hirotoshi Suzuki, Akio Sugiyama, Tadashi Clin Case Rep Case Reports We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled. John Wiley and Sons Inc. 2020-01-03 /pmc/articles/PMC7044355/ /pubmed/32128186 http://dx.doi.org/10.1002/ccr3.2645 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Kawaguchi, Yo
Hanaoka, Jun
Hayashi, Hideki
Fukuda, Yoshihisa
Iihara, Hirotoshi
Suzuki, Akio
Sugiyama, Tadashi
Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
title Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
title_full Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
title_fullStr Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
title_full_unstemmed Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
title_short Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
title_sort clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044355/
https://www.ncbi.nlm.nih.gov/pubmed/32128186
http://dx.doi.org/10.1002/ccr3.2645
work_keys_str_mv AT kawaguchiyo clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis
AT hanaokajun clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis
AT hayashihideki clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis
AT fukudayoshihisa clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis
AT iiharahirotoshi clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis
AT suzukiakio clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis
AT sugiyamatadashi clinicalefficacyofosimertinibforapatientwithileusduetoperitonealcarcinomatosis